United States: The "Key-Stoned State": Employer's Guide To The Pennsylvania Medical Marijuana Law

Last Updated: June 1 2016
Article by Samuel Sverdlov, Jacob Oslick and Meredith-Anne Berger

Can a bistro in Pottsville, Pa. fire employees for using medical cannabis? Not anymore. On Tuesday, May 17, 2016, the Pennsylvania Medical Marijuana Act (SB-3) ("MMA") went into effect, following Governor Tom Wolf's signature last month (as previously reported here). Pennsylvania joins 24 other states, including New York, New Jersey and Connecticut, on the Pineapple Express. Along the way, employers will learn their ability to discipline employees for consuming medical marijuana on the job, for showing up to work under the influence of medical marijuana, and other unintended consequences that will bud from the law.

Overview of the Law

The MMA permits people diagnosed with a "serious medical condition,[1]" and who meet the act's certifications requirement to use medical marijuana. However, the MMA adopts a much more restrictive approach than many other state medical marijuana laws. Under the MMA, individuals certified to use medical marijuana cannot smoke it. They can only dose using a pill, oil, topical form, a form suitable for vaporization or nebulization, tincture or liquid.[2] So blunts, bongs, and hookahs are out. But brownies baked with cannabis oil appear to be ok.

Impact on the Workplace

Under the MMA, employers are prohibited from threatening to discharge, discharging, refusing to hire or otherwise discriminating or retaliating against an employee because the employee is certified to use medical marijuana. Despite this robust protection for medical marijuana users, employers do not need to permit employees to use medical marijuana in the workplace.

Since medical marijuana use remains illegal under federal law, Pennsylvania employers need not accommodate employees under the Americans with Disabilities Act. Nor do they need to put themselves (or their agents) in a position that violates federal law — a provision that was likely intended to provide a safe harbor for federal contractors and heavily-regulated employers in sensitive industries. So the blunt truth is that employees who work in glass houses for the federal government probably still can't get stoned.

The MMA hides several other employer-friendly provisions in the smoke.

  • From our reading of the law, an employer may always discipline an employee if he or she is under the influence of medical marijuana while working. However, there is an alternate interpretation holding that employers can always discipline an employee for being under the influence in the workplace, but if employees are working under the influence of medical marijuana outside of the workplace (such as outside sales people), employers may only discipline those employees whose performance falls below the standard of care normally accepted for that position. Absent any further guidance by the legislature, the courts will likely decide which reading is correct.
  • Employees under the influence of medical marijuana while working, regardless of whether they are in the workplace, are expressly prohibited from performing particularly sensitive jobs such as "any employment duties at heights or in confined spaces, including, but not limited to, mining" or working with certain chemicals and high-voltage electronics.
  • Employers also have the option to prohibit employees who are under the influence of marijuana while working from: (1) "performing any task which the employer deems life-threatening, to either the employee or any of the employees of the employer"; or (2) "performing any duty which could result in a public health or safety risk." This is true, even if the employee is working outside the workplace and the employee's conduct does not fall below the standard of care normally accepted for that position. It remains to be seen what kinds of duties would fall under these categories. This provision may extend to employees that work with children, the elderly, and the mentally ill, and litigation is possible over the breadth of this provision. In either circumstance, the employer's imposition of a limitation would not be considered an "adverse action" even if it resulted in a financial detriment to the employee.

Outlook for Employers

In light of the MMA, employers should make sure that they do not discriminate or retaliate against employees who use medical marijuana. However, employers may still prohibit employees from working under the influence of medical marijuana. Employers may also require a drug-free workplace and maintain a drug-testing program that provides accommodations for medical marijuana users. And certain federal contractors and other employers may still be able to exclude medical marijuana users from sensitive jobs (such as jobs where applicable statutes or regulations require employees to pass random drug tests).

Employers should also consider including provisions in its employee handbook about the use of medical marijuana, and develop specific policies regarding restrictions of particular duties for medical marijuana users. In administrating such policies, employers should take care not to divulge any personal medical information of the employee to people who do not need to know. For the most part, it should be sufficient to inform supervisors that the employee has a specific work restriction or needs a particular accommodation: rarely will a supervisor need to know that an employee is using medical marijuana. To that end, it may be preferable for employers to allow employees to go directly to Human Resources when requesting accommodations, by-passing their supervisors or managers.

Employers who do not tread carefully may find themselves in violation of the Pennsylvania Human Relations Act, as well as the non-retaliation provision of the MMA.


[1] The statute defines the following as "serious medical conditions:" cancer, positive status for human immunodeficiency virus or acquired immune deficiency syndrome, Amyotrophic lateral sclerosis, Parkinson's disease, Multiple Sclerosis, damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity, Epilepsy, Inflammatory bowel disease, neuropathies, Huntington's disease, Crohn's disease, post-traumatic stress disorder, intractable seizures, glaucoma, sickle cell anemia, severe chronic or intractable pain of neuropathic origin or severe chronic or intractable pain in which conventional therapeutic intervention and opiate therapy is contraindicated or ineffective, and autism.

[2] Edible products cannot be sold but patients can create their own.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Samuel Sverdlov
Meredith-Anne Berger
Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions